WO2003018793A1 - Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques - Google Patents

Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques Download PDF

Info

Publication number
WO2003018793A1
WO2003018793A1 PCT/JP2002/008408 JP0208408W WO03018793A1 WO 2003018793 A1 WO2003018793 A1 WO 2003018793A1 JP 0208408 W JP0208408 W JP 0208408W WO 03018793 A1 WO03018793 A1 WO 03018793A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
guanine nucleotide
nucleotide exchange
exchange factor
same
Prior art date
Application number
PCT/JP2002/008408
Other languages
English (en)
Japanese (ja)
Inventor
Shuichiro Inagaki
Yoshihiro Kawamura
Original Assignee
Shionogi & Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co., Ltd. filed Critical Shionogi & Co., Ltd.
Priority to JP2003523642A priority Critical patent/JP4219808B2/ja
Publication of WO2003018793A1 publication Critical patent/WO2003018793A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne un nouveau polypeptide présentant une séquence (SecL-1) de type facteur d'échange de nucléotides guanyliques humains et de souris et un gène codant ledit polypeptide ; un polypeptide de recombinaison faisant appel à la séquence d'ADN codant le polypeptide susmentionné et un procédé de production afférent ; un anticorps le reconnaissant spécifiquement et un procédé de production afférent ; un inhibiteur de prolifération cellulaire, un agent induisant l'apoptose et un remède contre les maladies du foie le contenant ; une méthode de criblage d'un composé qui régule spécifiquement la protéine susmentionnée à l'aide dudit polypeptide, etc.
PCT/JP2002/008408 2001-08-23 2002-08-21 Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques WO2003018793A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003523642A JP4219808B2 (ja) 2001-08-23 2002-08-21 グアニンヌクレオチド交換因子様配列を有する新規遺伝子

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001253344 2001-08-23
JP2001-253344 2001-08-23

Publications (1)

Publication Number Publication Date
WO2003018793A1 true WO2003018793A1 (fr) 2003-03-06

Family

ID=19081693

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008408 WO2003018793A1 (fr) 2001-08-23 2002-08-21 Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques

Country Status (2)

Country Link
JP (1) JP4219808B2 (fr)
WO (1) WO2003018793A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (fr) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001029221A2 (fr) * 1999-10-20 2001-04-26 Zymogenetics, Inc. Nouvelles proteines et polynucleotides codant ces proteines
WO2001032676A1 (fr) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 25 proteines secretes par l'homme
WO2001053453A2 (fr) * 1999-12-23 2001-07-26 Hyseq, Inc. Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
WO2001059063A2 (fr) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (fr) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001029221A2 (fr) * 1999-10-20 2001-04-26 Zymogenetics, Inc. Nouvelles proteines et polynucleotides codant ces proteines
WO2001032676A1 (fr) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 25 proteines secretes par l'homme
WO2001053453A2 (fr) * 1999-12-23 2001-07-26 Hyseq, Inc. Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
WO2001059063A2 (fr) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ACHSTETTER T. ET AL.: "SEC7 encodes an unusual, high molecular weight protein required for membrane traffic from the yeast golgi apparatus", J. BIOL. CHEM., vol. 263, no. 24, 1988, pages 11711 - 11717, XP002040610 *
AKIRA TOGAWA ET AL.: "Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors", J. BIOL. CHEM., vol. 274, no. 18, 1999, pages 12308 - 12315, XP002966803 *
MORINAGA N. ET AL.: "Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor", PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 12926 - 12931, XP002966802 *

Also Published As

Publication number Publication date
JP4219808B2 (ja) 2009-02-04
JPWO2003018793A1 (ja) 2004-12-09

Similar Documents

Publication Publication Date Title
WO2001018172A3 (fr) Polypeptides de type facteur de croissance des fibroblastes
WO2001070174A8 (fr) Genes modules par vegf et leurs procedes d'utilisation
WO2002074979A3 (fr) Profils d'expression et methodes d'utilisation
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
WO2003016475A3 (fr) Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur
WO2003052118A3 (fr) Beta-glucosidase bgl4 et acides nucleiques la codant
WO2003020916A8 (fr) Acides nucleiques codant des proteines de soie d'araignee, polypeptides de soie d'araignee, anticorps specifiques des polypeptides de soie d'araignee et leurs procedes d'utilisation
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DE60313866D1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
WO2004053137A3 (fr) Procede de production de proteines
DK1098991T3 (da) Hidtil ukendte fremgangsmåder til identifikation af ligand- og målbiomolekyler
BR0214542A (pt) Célula hospedeira, sistema de expressão, e, processos de preparação de uma célula hospedeira, e de uma proteìna alvo
AU2002323249A1 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
WO2001016324A3 (fr) Methodes et compositions d'un nouvel inhibiteur de serine protease
WO2003018793A1 (fr) Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques
AU2003247537A1 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
WO2002090500A3 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
WO2000066735A3 (fr) Nouvelles proteines de canal ionique de l'homme
EP1236800A3 (fr) Acides nucléiques encodant l'interféron alpha 2, contenant des polymorphismes mononucléotidiques et procédés d'utilisation de ces acides
WO2005049793A3 (fr) Methodes et compositions destinees a des approches combinatoires pour la therapie genique du cancer
CA2348732A1 (fr) Proteines humaines h37 et adnc les codant
WO2002063009A3 (fr) Proteines de mammiferes lp et reactifs associes
WO2003012120A3 (fr) Proteine secretee de mammifere lp354
BR9915537A (pt) Gene prv-1 e sua utilização
HUP0400915A2 (hu) Növényi reprodukciós proteinek

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003523642

Country of ref document: JP

122 Ep: pct application non-entry in european phase